Details of the Drug Reposition

General Information of This Drug (ID: DMCT8EY)

Drug Name
Cenderitide   DMCT8EY

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Heart disease DISKW5KW BA41-BA42 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Heart failure DISJW62S BD10-BD13 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressurein a proof-of-concept study in patients with chronic heart failure. BMC Pharmacol. 2011; 11(Suppl 1): P18.
2 2011 Pipeline of Nile Therapeutics.